A PHASE 2 TRIAL OF COMBINED LUTETIUM PSMA THERANOSTICS AND DOCETAXEL IN NEWLY DIAGNOSED METASTATIC HORMONE NAIVE PROSTATE CANCER
$821,790FY2019Department of the ArmyDOD
University Of Melbourne, Melbourne
Investigators
View source on USAspending →A PHASE 2 TRIAL OF COMBINED LUTETIUM PSMA THERANOSTICS AND DOCETAXEL IN NEWLY DIAGNOSED METASTATIC HORMONE NAIVE PROSTATE CANCER · GrantIndex